ATHERSYS Aktie

1,12 EUR 2,7523%

Zu Ihrem Onlinebroker

kaufen verkaufen

ATHERSYS Aktienkurs : 24.05. ( 15 Min. verzögert)
1,12 € Letzter Kurs	2,75% Veränderung	1,09 € Vortag	1,05 € Eröffnungskurs

mehr Informationen

Hoch/Tief		Volumen		Geldkurs	Briefkurs
1,12 - 1,05 Tag	0,0000000 - 0,0000000 52 Wochen	0 Tag	4 Ø 52 Wochen	0,0000000 0 Stücke	0,0000000 0 Stücke

ATHERSYS Aktienkurs

Wollen Sie wissen, wie es mit dieser Aktie weitergeht?
Wir informieren Sie kostenlos.

Erhalten Sie außerdem Expertenanalysen von:
Gevestor Täglich und John Gossens Daily DAX

24.05.

“Where's the beef”, OSIR recaptures gain as sector wavers

Athersys (ATHX), BioLife Solutions (OTC BB: BLFS), BioMimetic (BMTI), Cryo-Cell (OTC BB: CCEL), Geron (GERN), Neuralstem (Amex: CUR), StemCells (STEM), Neuralstem (Amex: CUR), Opexa (OPXA), ReNeuron …
23.05.

Why is Athersys suddenly hyping its preclinical obesity drug?

... drug that hasn't yet been tested in humans and is at best years and years away from generating any sales, but Athersys (NASDAQ:ATHX) CEO Gil Van Bokkelen did his best in a recent conference ...

18.05.

KeyCorp's Beth Mooney shares her views from the CEO suite

Keep up the momentum: Athersys Inc. of Cleveland is mentioned in this Reuters story about companies making progress in the treatment of acute graft-versus host...
18.05.

KeyCorp's Beth Mooney shares her views from the CEO suite

Keep up the momentum: Athersys Inc. of Cleveland is mentioned in this Reuters story about companies making progress in the treatment of acute graft-versus host...
17.05.

Pioneers in Regenerative Medicine Reshaping the Landscape of Biotechnology

... bought by Sanofi-Aventis (NYSE: SNY) for $20.1 billion; Geoff MacKay, CEO at privately-held Organogenesis, Inc.; and Gil Van Bokkelen, CEO at Athersys, ...